)
Deborah Richards
VP & General Manager, Rare Disease UK & Ireland,
Alexion, AstraZeneca
Sessions
-
Panel Discussion: Designing the Next Generation of Rare Disease Therapies: From Advanced Genomics to AI-Enabled Therapeutic Innovation27-Jan-2027Advanced Therapies Stage